BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9211161)

  • 1. Effect of a commercial disinfectant ('Virkon') on mouse experimental infection by Cryptosporidium parvum.
    Ares-Mazás E; Lorenzo MJ; Casal JA; Fernández da Ponte B; Castro JA; Freire F
    J Hosp Infect; 1997 Jun; 36(2):141-5. PubMed ID: 9211161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of amine-based disinfectant KENO™COX on the infectivity of Cryptosporidium parvum oocysts.
    Naciri M; Mancassola R; Fort G; Danneels B; Verhaeghe J
    Vet Parasitol; 2011 Jun; 179(1-3):43-9. PubMed ID: 21354705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimycobacterial activity of 'Virkon'.
    Broadley SJ; Furr JR; Jenkins PA; Russell AD
    J Hosp Infect; 1993 Mar; 23(3):189-97. PubMed ID: 8099093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of selected disinfectants against mycobacteria and cryptosporidia.
    Holton J; Nye P; McDonald V
    J Hosp Infect; 1994 Jun; 27(2):105-15. PubMed ID: 7930537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of two commercial disinfectants on the viability and infectivity of Cryptosporidium parvum oocysts.
    Castro-Hermida JA; Pors I; Méndez-Hermida F; Ares-Mazás E; Chartier C
    Vet J; 2006 Mar; 171(2):340-5. PubMed ID: 16490718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ultraviolet disinfection of drinking water on the viability of Cryptosporidium parvum oocysts.
    Lorenzo-Lorenzo MJ; Ares-Mazas ME; Villacorta-Martinez de Maturana I; Duran-Oreiro D
    J Parasitol; 1993 Feb; 79(1):67-70. PubMed ID: 8437060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of two peroxygen-based disinfectants for inactivation of Cryptosporidium parvum oocysts.
    Quilez J; Sanchez-Acedo C; Avendaño C; del Cacho E; Lopez-Bernad F
    Appl Environ Microbiol; 2005 May; 71(5):2479-83. PubMed ID: 15870337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Highly Active AntiRetroviral Therapy and cryptosporidiosis].
    Morales Gomez MA
    Parassitologia; 2004 Jun; 46(1-2):95-9. PubMed ID: 15305695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re: Antimycobacterial activity of 'Virkon'.
    Auchincloss TR
    J Hosp Infect; 1993 Dec; 25(4):301-4. PubMed ID: 7907629
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of salinity, temperature and storage time on mouse experimental infection by Cryptosporidium parvum.
    Freire-Santos F; Oteiza-López AM; Vergara-Castiblanco CA; Ares-Mazás ME
    Vet Parasitol; 1999 Nov; 87(1):1-7. PubMed ID: 10628695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do iodine water purification tablets provide an effective barrier against Cryptosporidium parvum?
    Butkus MA; Starke JA; Bowman DD; Labare M; Fogarty EA; Lucio-Forster A; Barbi J; Jenkins MB; Pavlo M
    Mil Med; 2005 Jan; 170(1):83-6. PubMed ID: 15724860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of activated sludge in removing Cryptosporidium parvum oocysts from sewage.
    Villacorta-Martinez de Maturana I; Ares-Mazás ME; Duran-Oreiro D; Lorenzo-Lorenzo MJ
    Appl Environ Microbiol; 1992 Nov; 58(11):3514-6. PubMed ID: 1482177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gaseous disinfection of Cryptosporidium parvum oocysts.
    Fayer R; Graczyk TK; Cranfield MR; Trout JM
    Appl Environ Microbiol; 1996 Oct; 62(10):3908-9. PubMed ID: 8837451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bromine and Chlorine Disinfection of
    Coleman CK; Kim J; Bailey ES; Abebe LS; Brown J; Simmons OD; Sobsey MD
    Environ Sci Technol; 2023 Nov; 57(47):18744-18753. PubMed ID: 37220325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of common laboratory disinfectants on the infectivity of Cryptosporidium parvum oocysts in cell culture.
    Weir SC; Pokorny NJ; Carreno RA; Trevors JT; Lee H
    Appl Environ Microbiol; 2002 May; 68(5):2576-9. PubMed ID: 11976138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of the mixed-oxidant solution on infectivity of Cryptosporidium parvum oocysts in a neonatal mouse model].
    Sasahara T; Aoki M; Sekiguchi T; Takahashi A; Satoh Y; Kitasato H; Inoue M
    Kansenshogaku Zasshi; 2003 Feb; 77(2):75-82. PubMed ID: 12661082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculocidal activity of a peroxymonosulphate-based disinfectant-detergent (Virkon).
    De Lorenzi S; Finzi G; Mosca B; Salvatorelli G
    J Hosp Infect; 2008 Jan; 68(1):96-7. PubMed ID: 18069085
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of in vitro efficacy of the disinfectant Virkon.
    Gasparini R; Pozzi T; Magnelli R; Fatighenti D; Giotti E; Poliseno G; Pratelli M; Severini R; Bonanni P; De Feo L
    Eur J Epidemiol; 1995 Apr; 11(2):193-7. PubMed ID: 7672075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of cell culture and quantitative PCR (cc-qPCR) to assess disinfectants efficacy on Cryptosporidium oocysts under standardized conditions.
    Shahiduzzaman M; Dyachenko V; Keidel J; Schmäschke R; Daugschies A
    Vet Parasitol; 2010 Jan; 167(1):43-9. PubMed ID: 19850414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of in vitro evaluation of chemical disinfectants for efficacy on Cryptosporidium parvum oocysts.
    Delling C; Lendner M; Müller U; Daugschies A
    Vet Parasitol; 2017 Oct; 245():5-13. PubMed ID: 28969838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.